PMV Pharmaceuticals(PMVP) - 2025 Q1 - Quarterly Results

Exhibit 99.1 PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights PRINCETON, N.J., May 9, 2025 (GLOBE NEWSWIRE) - PMV Pharmaceuticals, Inc. ("PMV Pharma" or the "Company"; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor- agnostic therapies targeting p53, today reported financial results for the first quarter ended March 31, 2025, and provided a corporate update. "Our registrational PYNNACLE trial continues to ...